Fragment c gamma receptor gene polymorphisms and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians

Breast Cancer Research and Treatment

Volumn 126, Issue 2, 2011, Pages 497-505

  Iwasaki, Motoki ^a   Shimada, Naoki ^b   Kasuga, Yoshio ^c   Yokoyama, Shiro ^d   Onuma, Hiroshi ^d   Nishimura, Hideki ^e   Kusama, Ritsu ^f   Hamada, Gerson S ^g   Nishimoto, Ines N ^h   Iyeyasu, Hirofumi ^h   Motola Jr , Juvenal ⁱ   Laginha, Fábio M ⁱ   Anzai, Roberto ^j   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c Nagano Matsushiro General Hospital   (Japan)

^d NAGANO RED CROSS HOSPITAL   (Japan)

^e Nagano Municipal Hospital   (Japan)

^f Nagano Hokushin General Hospital   (Japan)

^g Nikkei Disease Prevention Center   (Brazil)

^h A C CAMARGO CANCER CENTER   (Brazil)

ⁱ Hospital Perola Byington   (Brazil)

^j Hospital Santa Cruz   (Brazil)

more..

Author keywords

Breast cancer; Case control study; Fragment c gamma receptor gene; Immigrants; Single nucleotide polymorphism

Indexed keywords

ARGININE; FC RECEPTOR; FC RECEPTOR IIA; FC RECEPTOR IIIA; GENOMIC DNA; HISTIDINE; PHENYLALANINE; UNCLASSIFIED DRUG; VALINE;

ADULT; AGED; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BRAZIL; BRAZILIAN; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IMMUNOPATHOGENESIS; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRAZIL; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; JAPAN; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RECEPTORS, IGG; RECEPTORS, PROGESTERONE; RISK FACTORS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 79958726514     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1109-3     Document Type: Article

References (28)

1. Ferlay J, Bray F, Pisani P et al (2004) GLOBOCAN 2002 cancer incidence, mortality and prevalence worldwide. IARC Cancer-Base No. 5, version 2.0. IARC Press, Lyon
2. Matsuda T, Marugame T, Kamo K et al (2009) Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol 39:850-858
3. Key T, Appleby P, Barnes I et al (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606-616 (Pubitemid 34498648)
4. Finn OJ (2008) Cancer immunology. N Engl J Med 358: 2704-2715
5. Imai K, Matsuyama S, Miyake S et al (2000) Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356:1795-1799
6. Dewan MZ, Takada M, Terunuma H et al (2009) Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients. Biomed Pharmacother 63:703-706
7. Reuschenbach M, von Knebel Doeberitz M, Wentzensen N (2009) A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother 58:1535-1544
8. Croce MV, Isla Larrain MT, Price MR et al (2001) Detection of circulating mammary mucin (Muc1) and MUC1 immune complexes (Muc1-CIC) in healthy women. Int J Biol Markers 16:112-120 (Pubitemid 32755128)
9. Croce MV, Isla Larrain MT, Capafons A et al (2001) Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women. Breast Cancer Res Treat 69:1-11 (Pubitemid 33079024)
10. Forsman LM, Jouppila PI, Andersson LC (1984) Sera from multiparous women contain antibodies mediating cytotoxicity against breast carcinoma cells. Scand J Immunol 19:135-139 (Pubitemid 14194674)
11. Koene HR, Kleijer M, Algra J et al (1997) Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood 90:1109-1114 (Pubitemid 27314146)
12. Dall'Ozzo S, Tartas S, Paintaud G et al (2004) Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship. Cancer Res 64:4664-4669 (Pubitemid 38856941)
13. Salmon JE, Edberg JC, Brogle NL et al (1992) Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 89:1274-1281
14. Warmerdam PA, van de Winkel JG, Vlug A et al (1991) A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 147:1338-1343
15. Spector NL, Blackwell KL (2009) Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol 27: 5838-5847
16. Musolino A, Naldi N, Bortesi B et al (2008) Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer. J Clin Oncol 26:1789-1796
17. van Sorge NM, van der Pol WL, van de Winkel JG (2003) FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 61:189-202 (Pubitemid 36605541)
18. Iwasaki M, Hamada GS, Nishimoto IN et al (2009) Dietary isoflavone intake and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Breast Cancer Res Treat 116:401-411
19. Shimada N, Iwasaki M, Kasuga Y et al (2009) Genetic polymorphisms in estrogen metabolism and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians. J Hum Genet 54:209-215
20. Wang SS, Cerhan JR, Hartge P et al (2006) Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 66:9771-9780 (Pubitemid 44623679)
21. Kyogoku C, Dijstelbloem HM, Tsuchiya N et al (2002) Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46:1242-1254 (Pubitemid 34525832)
22. Metes D, Ernst LK, Chambers WH et al (1998) Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene. Blood 91:2369-2380 (Pubitemid 28155511)
23. Suzuki R, Orsini N, Saji S et al (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status - a meta-analysis. Int J Cancer 124:698-712
24. World Cancer Research Fund and American Institute for Cancer Research (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective. American Institute, Washington, DC
25. Curado MP, Edwards B, Shin HR et al (2007) cancer incidence in five continents, vol IX. IARC Scientific Publications No. 160. IARC, Lyon
26. Althuis MD, Fergenbaum JH, Garcia Closas M et al (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomark Prev 13:1558-1568 (Pubitemid 39331875)
27. Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874 (Pubitemid 32878711)
28. Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502 (Pubitemid 43854964)